Another BET inhibitor, OTX015, is effective against mouse and human MYCN-driven neuroblastoma in models, as it can selectively disrupt the binding of BRD4 and SEs and lead to the repression of MYCN expression95. Here, BRD4 is linked to neuroblastoma.